TKNO: Alpha Teknova, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 119.33
Enterprise Value ($M) 100.42
Book Value ($M) 99.65
Book Value / Share 2.45
Price / Book 1.20
NCAV ($M) 12.35
NCAV / Share 0.30
Price / NCAV 9.67

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.39

Liquidity (mrq)
Quick Ratio 4.75
Current Ratio 6.13

Balance Sheet (mrq) ($M)
Current Assets 51.08
Assets 138.38
Liabilities 38.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Telegraph Hill Partners IV, L.P. 62.90 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-03-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-23 1,223 4,954 24.69
2024-02-22 1,318 23,916 5.51
2024-02-21 589 7,081 8.32
2024-02-20 653 33,607 1.94

(click for more detail)

Similar Companies
TBPH – Theravance Biopharma, Inc. TCRX – TScan Therapeutics, Inc.
TENK – TenX Keane Acquisition TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io